Genome Therapeutics Completes Merger, Raises $88.2M in Stock Offering

Feb 09, 2004

NEW YORK, Feb. 9 (GenomeWeb News) - Genome Therapeutics has completed its merger with Genesoft Pharmaceuticals and its common stock offering, the company said on Friday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Weigh the Knowledge

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

Diving into Gene-Editing Data

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Scramble for Tissue

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

This Week in Nature

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.

Main menu